abstract |
ABT-263 free base and its crystalline forms are active pharmaceutical ingredients suitable for pharmaceutical compositions useful for the treatment of diseases, eg, cancer, characterized by overexpression of one or more anti-apoptotic Bcl-2 class proteins. |